Thrombotic microangiopathy in the maternity ward from the anaesthesiologist‘s perspective – a case study
Authors:
N. Čechák; P. Nosková
Authors‘ workplace:
Klinika anesteziologie, resuscitace a intenzivní medicíny 1. LF UK a VFN v Praze
Published in:
Transfuze Hematol. dnes,32, 2026, No. 2, p. 136-139.
Category:
Case Reports
doi:
https://doi.org/10.48095/cctahd202603
Overview
Thrombotic microangiopathies (TMAs) represent a major diagnostic and therapeutic challenge in obstetrics; any delay increases maternal mortality and morbidity. We describe the case of a 29-year-old multiparous woman (second delivery) in whom an eclamptic seizure necessitated an emergency caesarean section. Persistent severe hypertension, together with acute renal failure, microangiopathic non-immune haemolytic anaemia, and thrombocytopenia, led to the rapid diagnosis of complement-mediated TMA (cmTMA/atypical haemolytic uraemic syndrome). Prompt initiation of complement inhibition therapy (eculizumab) in combination with temporary intermittent haemodialysis resulted in recovery of renal function. This case highlights the importance of early differential diagnosis of TMA in pregnancy and the benefit of targeted complement-inhibitory therapy.
Keywords:
plasmapheresis – Eclampsia – Thrombocytopenia – caesarean section – atypical haemolytic uremic syndrome – microangiopathic haemolytic anaemia – HELLP
Sources
1. Che M, Moran S, Smith R, et al. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy. Kidney Int. 2024; 105 (5): 960–970. doi: 10.1016/j.kint.2023.12.021.
2. Fakhouri F, Scully M, Provôt F, et al. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group. Blood. 2020; 136 (19): 2103–2117. doi: 10.1182/blood.2020005221.
3. Urra M, Lyons S, Teodosiu C, et al. Thrombotic microangiopathy in pregnancy: current understanding and management strategies. Kidney Int Rep. 2024; 9 (8): 2353–2371. doi: 10.1016/j.ekir.2024.05.016.
4. Ryšavá R. Stručné představení doporučeného postupu – Trombotické mikroangiopatie v graviditě a po porodu (sympozium AstraZeneca), Přednáška, Pařízkovy dny, 13.3.2025.
5. Koucký M, Toman A, Ryšavá R, Pařízek A. Vnitřní postup Kliniky gynekologie, porodnictví a neonatologie 1.LF UK a VFN 2020.
6. Koucký M, Toman A, Ryšavá R, Pařízek A. Trombotické mikroangiopatie a těhotenství. Ceska Gynekol. 2020; 85 (1): 18–28.
7. Ferrari B, Peyvandi F. How I treat thrombotic thrombocytopenic purpura in pregnancy. Blood. 2020; 136 (19): 2125–2132. doi: 10.1182/blood.2019000962.
8. Giannubilo SR, Marzioni D, Tossetta G, Ciavattini, A. HELLP syndrome and differential diagnosis with other thrombotic microangiopathies in pregnancy. Diagnostics. 2024; 14 (4): 352. doi: 10.3390/diagnostics14040352.
9. Vachek J, Zakiyanov O, Motáň V, Tesař V. Trombotická mikroangiopatie z pohledu nefrologa. Gastroent Hepatol. 2015; 69 (3): 262–266. doi: 10.14735/amgh2015262.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2026 Issue 2
Most read in this issue
- Thrombotic microangiopathy in the maternity ward from the anaesthesiologist‘s perspective – a case study
- Implementation of the SoHO Regulation and the Management of the Plasma Collection System in the Czech Republic – discussion and position of an interdisciplinary panel
- Development of the epidemiological situation of Hodgkin’s lymphoma in the Czech Republic in the period 2000–2019
- The change of prognosis of 1,492 nonselected patients with multiple myeloma during 60 years in the Middle and partially in the North Moravia region